| Code | Description | Claims | Beneficiaries | Total Paid |
| 99199 |
Unlisted special service, procedure or report |
50,116 |
30,844 |
$295K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,561 |
3,537 |
$267K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,102 |
2,727 |
$160K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
559 |
383 |
$52K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
924 |
645 |
$29K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
219 |
187 |
$18K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
372 |
225 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
455 |
265 |
$6K |
| 92551 |
|
1,210 |
799 |
$5K |
| 81003 |
|
3,238 |
2,356 |
$5K |
| 99383 |
|
42 |
29 |
$4K |
| 99384 |
|
35 |
27 |
$3K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
115 |
74 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
456 |
335 |
$3K |
| 96127 |
|
1,120 |
724 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
169 |
107 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
67 |
43 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
954 |
737 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
55 |
52 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
20 |
13 |
$1K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
18 |
12 |
$1K |
| 99173 |
|
1,195 |
829 |
$855.69 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
71 |
52 |
$693.08 |
| 80305 |
|
60 |
41 |
$462.74 |
| 82962 |
|
368 |
290 |
$457.60 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
15 |
15 |
$421.74 |
| 87276 |
|
30 |
28 |
$367.38 |
| 87275 |
|
30 |
28 |
$367.38 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
14 |
14 |
$328.44 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
29 |
28 |
$263.34 |
| 90674 |
|
53 |
44 |
$147.16 |
| 93000 |
|
26 |
13 |
$127.73 |
| 90686 |
|
50 |
24 |
$52.03 |
| 85018 |
|
19 |
17 |
$26.28 |
| 3074F |
|
33 |
28 |
$0.00 |